Abiopharma

Clinical trial NCT07170917 updates: 1. completion date: 2028-04-27 → 2029-11-23 2. primary completion date: 2027-08-01 → 2027-02-09

Clinical trial NCT07329322 updates: 1. enrollment: 60 → 30 participants 2. allocation: RANDOMIZED → NA 3. intervention model: PARALLEL → SINGLE_GROUP

Clinical trial NCT04292574 updates: 1. completion date: 2025-05-31 → 2040-01-01 2. primary completion date: 2025-05-31 → 2040-01-01

Clinical trial NCT04008030: completion date: 2026-06-10 → 2027-03-23.

Clinical trial NCT04487080: completion date: 2027-11-30 → 2028-02-16.

Clinical trial NCT07738614 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-07-31

Clinical trial NCT06315491 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2025-10-01 → 2025-10-31 3. primary completion date: 2025-10-01 → 2025-10-31 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06854640: completion date: 2027-02-15 → 2027-01-17.

Clinical trial NCT05987956 updates: 1. allocation: RANDOMIZED → NA 2. intervention model: PARALLEL → SEQUENTIAL 3. masking: QUADRUPLE → NONE

New Form 3 - AMERISERV FINANCIAL INC /PA/ <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000707605-26-000048 <b>Size:</b> 3 KB

Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

Clinical trial NCT06027268 updates: 1. completion date: 2027-03-01 → 2027-08-01 2. primary completion date: 2026-09-01 → 2027-08-01

Clinical trial NCT05127226 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 70 → 71 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07628049: enrollment: 1808 → 1456 participants.

Clinical trial NCT07426419: start date: 2026-06-01 → 2026-09-01.